NDC 67457-928
Dactinomycin
Dactinomycin
Dactinomycin is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Llc. The primary component is Dactinomycin.
| Product ID | 67457-928_0e173ef5-d0f1-41c3-9b64-543195443310 |
| NDC | 67457-928 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Dactinomycin |
| Generic Name | Dactinomycin |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2017-11-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA203385 |
| Labeler Name | Mylan Institutional LLC |
| Substance Name | DACTINOMYCIN |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Actinomycin [EPC],Nucleic Acid Synthesis Inhibitors [MoA],Protein Synthesis Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |